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Abstract 
 
Background: Type 2 diabetes (T2DM) is the most common form of diabetes.  
Obesity is associated with both the development of T2DM and also the 
development of the complications of diabetes; increasing health care costs and 
morbidity and mortality.  Weight loss and control of blood glucose levels should be 
managed with a tailored eating plan developed in negotiation between the person 
with diabetes and their health care team.  It is essential that health care 
professionals are familiar with different strategies that achieve weight reduction, 
glycaemic and cardiovascular risk reduction goals.  One emerging weight reduction 
strategy is fasting diets.  There is currently a gap in the knowledge of whether 
fasting diets are an effective and safe weight reduction strategy for people with 
T2DM on insulin.   
 
Aim: To investigate the effectiveness and safety of an intermittent fasting diet (two 
day per week) as an alternative to standard dietary advice (portion control diet) for 
weight reduction in obese adults with insulin dependent T2DM attending a 12-week 
group based intervention at Waitemata District Health Board (DHB). 
 
Methods: 
Obese patients with T2DM treated with insulin who were attending Waitemata 
DHB Diabetes Service were recruited for this two arm open-label design 
intervention feasibility study.  Both dietary strategies were implemented during a 
12-week intervention at which participants received monthly dietitian-led group 
education and support.  The intermittent fasting diet (IFD) intervention (n=8) 
investigated was a two day per week reduced energy intake (550-650kcal / 2300-
2700kJ per day) and five days’ usual intake making low fat choices.  The portion 
control diet (PCD) was the comparison group (n=7) and focused on daily energy 
restriction through reduction in portion sizes and low fat food choices in line with 
current New Zealand dietary recommendations for management of T2DM.   
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Results: Similar weight loss was achieved in both groups (IFD: 2.7 ± 3.0 kg, PCD:      
1.7 ± 2.5 kg). This reduction was not significant between groups.  There was a 
significant difference between groups in reduction in HbA1c. (P=0.003) (IFD:              
-11 mmol/mol, PCD: -3 mmol/mol). This decrease was significant in the IFD group 
only (P=0.018).  Reported hypoglycaemic events were low in both groups (8 events 
in IFD; 21 events in PCD). Non-significant between group reductions in waist 
circumference (P=0.402), waist: height ratio (P=0.455), diastolic (P=0.189) and 
systolic blood pressure (P=0.443) were observed.  Lipid profile remained stable in 
both groups.   
 
Conclusion: This feasibility study showed that an intermittent fasting diet can 
achieve similar weight loss to current standard practice dietary advice in people 
with T2DM.  However, it is the significant reductions in HbA1c compared to a daily 
energy restriction diet over a three-month period seen in this study that warrant 
further investigation.  With education from health care professionals and 
modification of insulin on pre-fasting and fasting day this diet may be followed 
safely and hypoglycaemia avoided or managed appropriately.   
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